VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Ownership - Who Owns VYNE Therapeutics?

1,810 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 17, 2023
xxxxxxxxxxxxx
$50700

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
445,000Institution3.06%952,300
442,514Institution3.05%946,980
104,633Institution0.72%223,915
68,630Institution0.47%146,868
29,631Institution0.20%63,410
5,196Institution0.04%11,119
3,873Institution0.03%8,288
1,038Institution<0.01%2,221
1,025Institution<0.01%2,194

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
445,000Institution3.06%952,300
104,633Institution0.72%223,915
68,630Institution0.47%146,868
5,196Institution0.04%11,119
3,873Institution0.03%8,288
1,038Institution<0.01%2,221
1,025Institution<0.01%2,194

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
373,319Institution2.57%948,230
69,195Institution0.48%175,755
29,631Institution0.20%63,410

FAQ

Who Owns VYNE Therapeutics (VYNE)?
Currently, no data Available
What percentage of VYNE Therapeutics (VYNE) stock is held by institutional investors?
Currently, no data Available
What percentage of VYNE Therapeutics (VYNE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of VYNE Therapeutics (VYNE)?
MUTUAL FUND SERIES TRUST owns the most shares of VYNE Therapeutics (VYNE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis